These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26071627)

  • 1. Human recombinant lysosomal enzymes produced in microorganisms.
    Espejo-Mojica ÁJ; Alméciga-Díaz CJ; Rodríguez A; Mosquera Á; Díaz D; Beltrán L; Díaz S; Pimentel N; Moreno J; Sánchez J; Sánchez OF; Córdoba H; Poutou-Piñales RA; Barrera LA
    Mol Genet Metab; 2015; 116(1-2):13-23. PubMed ID: 26071627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in development of transgenic silkworms overexpressing recombinant human proteins with therapeutic potential in silk glands.
    Itoh K; Kobayashi I; Nishioka S; Sezutsu H; Machii H; Tamura T
    Drug Discov Ther; 2016 Feb; 10(1):34-9. PubMed ID: 26971553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting macrophages with baculovirus-produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis.
    Bonten EJ; Wang D; Toy JN; Mann L; Mignardot A; Yogalingam G; D'Azzo A
    FASEB J; 2004 Jun; 18(9):971-3. PubMed ID: 15084520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and characterization of a human lysosomal recombinant iduronate-2-sulfatase produced in Pichia pastoris.
    Pimentel N; Rodríguez-Lopez A; Díaz S; Losada JC; Díaz-Rincón DJ; Cardona C; Espejo-Mojica ÁJ; Ramírez AM; Ruiz F; Landázuri P; Poutou-Piñales RA; Cordoba-Ruiz HA; Alméciga-Díaz CJ; Barrera-Avellaneda LA
    Biotechnol Appl Biochem; 2018 Sep; 65(5):655-664. PubMed ID: 29633336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of Enzyme Drugs Derived from Transgenic Silkworms to Treat Lysosomal Diseases].
    Itoh K; Nishioka SI; Hidaka T; Tsuji D; Maita N
    Yakugaku Zasshi; 2018; 138(7):885-893. PubMed ID: 29962464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of recombinant proteins by microbes and higher organisms.
    Demain AL; Vaishnav P
    Biotechnol Adv; 2009; 27(3):297-306. PubMed ID: 19500547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective.
    Thomas R; Kermode AR
    Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New yeast expression platforms based on methylotrophic Hansenula polymorpha and Pichia pastoris and on dimorphic Arxula adeninivorans and Yarrowia lipolytica - a comparison.
    Gellissen G; Kunze G; Gaillardin C; Cregg JM; Berardi E; Veenhuis M; van der Klei I
    FEMS Yeast Res; 2005 Nov; 5(11):1079-96. PubMed ID: 16144775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polylysine-polyhistidine fusion peptide for lysosome-targeted protein delivery.
    Iwasaki T; Murakami N; Kawano T
    Biochem Biophys Res Commun; 2020 Dec; 533(4):905-912. PubMed ID: 33008588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lysosomes and lysosomal storage diseases].
    Germain DP
    J Soc Biol; 2002; 196(2):127-34. PubMed ID: 12360741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme replacement therapy for lysosomal storage diseases.
    Lachmann RH
    Curr Opin Pediatr; 2011 Dec; 23(6):588-93. PubMed ID: 21946346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of starvation-induced lysosomal activity in Saccharomyces cerevisiae.
    Yoon J; Chang ST; Park JS; Kim YH; Min J
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):283-9. PubMed ID: 20632003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Collagenolytic Aspartic Protease from Thermomucor indicae-seudaticae Expressed in Escherichia coli and Pichia pastoris.
    Pereira WES; da Silva RR; de Amo GS; Ruller R; Kishi LT; Boscolo M; Gomes E; da Silva R
    Appl Biochem Biotechnol; 2020 Jul; 191(3):1258-1270. PubMed ID: 32086706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of recombinant proteins by yeast cells.
    Celik E; Calık P
    Biotechnol Adv; 2012; 30(5):1108-18. PubMed ID: 21964262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative damage and redox in Lysosomal Storage Disorders: Biochemical markers.
    Donida B; Jacques CED; Mescka CP; Rodrigues DGB; Marchetti DP; Ribas G; Giugliani R; Vargas CR
    Clin Chim Acta; 2017 Mar; 466():46-53. PubMed ID: 28082023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glyco-engineering strategies for the development of therapeutic enzymes with improved efficacy for the treatment of lysosomal storage diseases.
    Oh DB
    BMB Rep; 2015 Aug; 48(8):438-44. PubMed ID: 25999178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From bedside to cell biology: a century of history on lysosomal dysfunction.
    Coutinho MF; Matos L; Alves S
    Gene; 2015 Jan; 555(1):50-8. PubMed ID: 25275857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yeast systems for the commercial production of heterologous proteins.
    Buckholz RG; Gleeson MA
    Biotechnology (N Y); 1991 Nov; 9(11):1067-72. PubMed ID: 1367623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment prospects of lysosomal storage disorders].
    Reismann P; Tulassay Z
    Orv Hetil; 2008 Jun; 149(25):1171-9. PubMed ID: 18547894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific analysis of N-linked oligosaccharides of recombinant lysosomal arylsulfatase A produced in different cell lines.
    Schröder S; Matthes F; Hyden P; Andersson C; Fogh J; Müller-Loennies S; Braulke T; Gieselmann V; Matzner U
    Glycobiology; 2010 Feb; 20(2):248-59. PubMed ID: 19864504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.